Security key
00430H201
Accelerate Diagnostics, Inc - Common Stock, $0.001 par value per share (AXDXQ)
CUSIP: 00430H201
Q2 2023 13F Holders as of 30 Jun 2023
- Security type / class
- Equity / Common Stock, $0.001 par value per share
- Total 13F shares
- 205,042
- Total 13F value
- $166,325
- Share change
- +205,042
- SEC-reported price per share
- $0.81
- Number of holders
- 2
- Value change
- +$166,325
- Number of buys
- 2
- Shares outstanding
- 25,187,879
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2023
Institutions
2
Top holders
2
AXDXQ full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Accelerate Diagnostics, Inc SEC filings
Accelerate Diagnostics, Inc company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00430H201
Recent filing periods:
Ownership snapshot
Top reported holders of AXDXQ - Accelerate Diagnostics, Inc - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
GRIFFIN ASSET MANAGEMENT,...
Disclosed value leader
GRIFFIN ASSET MANAGEMENT,...
Comparable rows
15/15
Latest evidence
31 Mar 2023
13F
Lead comparable stake: 37%
Showing 1-6 of 15 holder rows.
Quick read
GRIFFIN ASSET MANAGEMENT, INC. leads the comparable SEC ownership view at 37%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens GRIFFIN ASSET MANAGEMENT, INC.'s linked filing trail.
Comparable ownership
Top 5
GRIFFIN ASSET MANAGEMENT, INC.
37%
VANGUARD GROUP INC
10%
Birchview Capital, LP
8.1%
ORACLE INVESTMENT MANAGEMENT INC
5.4%
Alyeska Investment Group, L.P.
4.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| GRIFFIN ASSET MANAGEMENT, INC. |
13F
Company
|
37%
|
$7,174,444
10,249,206 shares
|
— | 31 Mar 2023 |
| VANGUARD GROUP INC |
13F
Company
|
10%
|
$2,013,734
2,876,763 shares
|
— | 31 Mar 2023 |
| Birchview Capital, LP |
13F
Company
|
8.1%
|
$1,577,000
2,252,388 shares
|
— | 31 Mar 2023 |
| ORACLE INVESTMENT MANAGEMENT INC |
13F
Company
|
5.4%
|
$1,057,458
1,510,654 shares
|
— | 31 Mar 2023 |
| Alyeska Investment Group, L.P. |
13F
Company
|
4.5%
|
$867,290
1,238,986 shares
|
— | 31 Mar 2023 |
| Cannell & Co. |
13F
Company
|
4%
|
$778,343
1,111,919 shares
|
— | 31 Mar 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
2
Shares
205,042
Rows available
2
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2023 vs Q3 2025 Across Filers
Q3 2025 holders
0
Q2 2023 holders
2
Holder diff
2
| Investor | Q3 2025 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q3 2025 value | Q2 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend